ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

FDC Ban and Endless Rounds of Litigation

Despite the recommendation of two expert committees to ban fixed dose combinations, the issue remains unresolved. Manufacturers of banned FDCs have approached Delhi High Court and sought to question the rationale of the ban on tendentious grounds. This also raises questions over the extent of judicial involvement in deciding upon the content of scientific matters.

AIDAN is a party to the Special Leave Petition along with the Union of India, as well as party to the 2018 cases in Delhi High Court and Supreme Court, mentioned in the article. Acknowledgements are due to legal counsel Colin Gonsalves and Tanya Agarwal, and author’s colleagues in AIDAN.
 

 

 

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Or

To gain instant access to this article (download).

Pay INR 50.00

(Readers in India)

Pay $ 6.00

(Readers outside India)

Updated On : 3rd Jan, 2019
Back to Top